Rheumatol Q: ()

Online Makale

Online Hizmetlere Toplu Bakış Online Kayıt ve Konaklama Online Bilimsel Program Dernekler İçin... Referanslarımız Telefon ve e-posta Desteği Bildiri özeti nedir? Bildiri özeti nasıl hazırlanır? Bildiri özeti örnekleri Kabul mektubu örnekleri

Rheumatol Q: ()

Ahead of Print
<< Back
CASE REPORT AND LITERATURE REVIEW
1.	Digital ulceration following gemcitabin plus cisplatin chemotherapy in a systemic sclerosis patient with lung adenocarcinoma Hüseyin Oruç, Reşit Yıldırım, Nazife Sule Yasar Bilge, Timuçin Kaşifoğlu Page 0 Abstract

INVITED REVIEW
2.	A review of baricitinib: The efficacy and safety in rheumatic diseases Ayten Yazıcı, Senar San Page 0 Abstract

3.	An Overview of Januz Kinase Inhibitors Dr Fatih Albayrak Page 0 Abstract

4.	Jak Inhibitors In Systemic Sclerosis: a Scoping Review Fatma Basibuyuk, Merih Birlik Page 0 Abstract

5.	JAK inhibitors in the treatment of systemic vasculitides FATMA ALIBAZ-ONER Page 0 Abstract

6.	Jakinibs in Systemic Lupus Erythematosus: Current Insights and Future Prospects Tuba Demirci Yıldırım, Ismail Sari Page 0 Abstract

7.	Tofacitinib: Current considerations in the management of immune inflammatory disorders Abdulsamet Erden Page 0 Abstract

8.	Upadacitinib in Action: Efficacy and Safety in the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis Fatma Basibuyuk, Ismail Sari Page 0 Abstract